Connect with us

World News

Pfizer’s vaccine will be adapted for the Omicron version in March – Ugur Sahin, CEO of BioNTech

Published

on

According to Ugur Sahin, CEO of BioNTech, Pfizer’s vaccine will be adapted for the Omicron version in March.

Even persons who have received three doses of one of the messenger RNA vaccines, according to the co-founder of the laboratory responsible for one of the vaccinations, can spread COVID.

Biostimulants would give protection to the tune of 70% to 75%.

The rapid spread of micron, which has prompted multiple countries in Europe to reinstate sanitary restrictions, has reawakened debate over the pandemic’s future, while details on the new variant’s transmissibility and virulence are still unknown.

 

“We must be conscious that even individuals who have been thrice vaccinated are likely to spread the illness,” – Ugur Sahin, executive director of BioNTech, said in an interview with the French daily Le Monde.

While the first data reveal that the vaccination is still efficacious against the Omicron strain, which is encouraging, the immunologist warned that the durability of this protection is unknown.

 

“Real life facts from the UK and South Africa provide us comforting knowledge,” said the Turkish-born researcher.

 

Discovery Health, South Africa’s largest private health insurance company, and Nhs England presented their assessments of the first Omicron contamination just a few days ago.

 

“Initial research from the United Kingdom suggests the effectiveness of roughly 70% after the third dose, and around 20% to 40% after the second dose.” stated the German specialist who creates the inoculants.

Advertisement

World News

Local News

Sports